## Core Concept
Anemia of chronic disease (ACD), also known as anemia of chronic inflammation, is a condition that occurs in patients with chronic infections, inflammatory conditions, or malignancies. It is characterized by a decrease in the production of erythropoietin (EPO) and a reduction in iron availability despite adequate iron stores. This condition results from the body's inflammatory response.

## Why the Correct Answer is Right
The correct answer, , typically represents a feature that is not characteristic of anemia of chronic disease. ACD is usually associated with:
- **Normocytic or microcytic anemia**: The anemia is often normocytic (normal MCV) but can be microcytic (low MCV) due to reduced iron availability.
- **Decreased EPO production**: The kidneys produce less EPO in response to chronic inflammation.
- **Increased hepcidin levels**: Hepcidin is a protein that regulates iron metabolism. In ACD, hepcidin levels are elevated, leading to decreased iron release from stores and reduced iron absorption from the gut.

## Why Each Wrong Option is Incorrect
- **Option A:** Typically represents a characteristic feature of ACD, such as normocytic anemia or decreased EPO production.
- **Option B:** Also represents a feature of ACD, like increased ferritin (indicating adequate or increased iron stores) or elevated hepcidin.
- **Option C:** Represents another characteristic, such as decreased serum iron but normal or increased ferritin.

## Clinical Pearl / High-Yield Fact
A key distinguishing feature of anemia of chronic disease from iron deficiency anemia is the presence of **increased ferritin** levels in ACD, indicating that the body has adequate iron stores but is unable to utilize them effectively due to inflammation.

## Correct Answer: D. Increased red cell production.
Anemia of chronic disease is actually characterized by a **decrease** in red blood cell production due to decreased EPO production and impaired iron utilization, not an increase.

**Correct Answer: D. Increased red cell production.**